Michael ZürcherMar 30, 20224 minSWIZZARD CHAMPIONS“The more firms there are, the more candidates move to Switzerland and the more attractive it gets"In our Swizzard Champions series, Michael Zürcher, CEO of Swizzard Pharma AG, interviews experienced thought leaders from the world of...
Michael ZürcherFeb 16, 20222 minINSIGHTSSwizzard Insight No. 4: Project Orbis – how to accelerate your oncology breakthroughs in SwitzerlandWhile the Food & Drug Administration (FDA) and the European Medicines Agency (EMA) are the regulatory bodies of the US and the European...
Michael ZürcherFeb 1, 20222 minCOMPANY NEWSA fantastic first year – Swizzard Pharma’s highlightsSwizzard is proud to have achieved some major milestones during 2021 – our year of foundation. In this review, we share some highlights...
Michael ZürcherJan 13, 20222 minTEAM & PARTNERSSwizzard Pharma AG joins Healthcare ShapersSwizzard Pharma AG, a solution provider to maximize the value of medical breakthroughs in Switzerland, is delighted to announce that CEO...
Michael ZürcherJan 7, 20221 minTEAM & PARTNERSJonas Mülchi joins the Board of Directors of Swizzard Pharma AGSwizzard Pharma AG, a provider of support services for biotech and pharma companies in Switzerland, has appointed Jonas Mülchi as Deputy...
Michael ZürcherDec 10, 20211 minTHREE TIPS FOR...Three Tips for...At Swizzard, we’re committed to helping biotech and pharma clients maximize their medical breakthroughs in Switzerland. One of the ways...